These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36310304)

  • 1. A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children.
    Papadopoulos KI; Papadopoulou A; Aw TC
    Hum Cell; 2023 Jan; 36(1):26-40. PubMed ID: 36310304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
    Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
    Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beauty and the beast: host microRNA-155 versus SARS-CoV-2.
    Papadopoulos KI; Papadopoulou A; Aw TC
    Hum Cell; 2023 May; 36(3):908-922. PubMed ID: 36847920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of renin angiotensin aldosterone system (RAAS), endothelial nitric oxide synthase (eNOS) and erythropoietin (EPO) on COVID-19 complications.
    Papadopoulos KI; Sutheesophon W; Aw TC
    Chem Biol Interact; 2022 Feb; 354():109834. PubMed ID: 35092718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
    Sur S; Steele R; Isbell TS; Ray R; Ray RB
    mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.
    Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR
    Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin 1-7 Stimulates Proliferation of Lung Bronchoalveolar Progenitors-Implications for SARS-CoV-2 Infection.
    Ciechanowicz AK; Lay WX; Prado Paulino J; Suchocki E; Leszczak S; Leszczak C; Kucia M
    Cells; 2022 Jul; 11(13):. PubMed ID: 35805187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
    Chang YS; Ko BH; Ju JC; Chang HH; Huang SH; Lin CW
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and genotype dependent erythropoietin protection in COVID-19.
    Papadopoulos KI; Sutheesophon W; Manipalviratn S; Aw TC
    World J Stem Cells; 2021 Oct; 13(10):1513-1529. PubMed ID: 34786155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.
    Yong YY; Zhang L; Hu YJ; Wu JM; Yan L; Pan YR; Tang Y; Yu L; Law BY; Yu CL; Zhou J; Li M; Qin DL; Zhou XG; Wu AG
    Clin Immunol; 2022 Nov; 244():109093. PubMed ID: 35944881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention.
    Zhang J; Ma X; Liu F; Zhang D; Ling J; Zhu Z; Chen Y; Yang P; Yang Y; Liu X; Zhang J; Liu J; Yu P
    Front Immunol; 2023; 14():1203389. PubMed ID: 37868953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
    Lécuyer D; Nardacci R; Tannous D; Gutierrez-Mateyron E; Deva Nathan A; Subra F; Di Primio C; Quaranta P; Petit V; Richetta C; Mostefa-Kara A; Del Nonno F; Falasca L; Marlin R; Maisonnasse P; Delahousse J; Pascaud J; Deprez E; Naigeon M; Chaput N; Paci A; Saada V; Ghez D; Mariette X; Costa M; Pistello M; Allouch A; Delelis O; Piacentini M; Le Grand R; Perfettini JL
    Front Immunol; 2023; 14():1270081. PubMed ID: 37920468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
    Zhao N; Di B; Xu LL
    Cytokine Growth Factor Rev; 2021 Oct; 61():2-15. PubMed ID: 34183243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications.
    Potere N; Del Buono MG; Caricchio R; Cremer PC; Vecchié A; Porreca E; Dalla Gasperina D; Dentali F; Abbate A; Bonaventura A
    EBioMedicine; 2022 Nov; 85():104299. PubMed ID: 36209522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors.
    Diarimalala RO; Wei Y; Hu D; Hu K
    Front Cell Infect Microbiol; 2023; 13():1218039. PubMed ID: 37360532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescuing fertility during COVID-19 infection: exploring potential pharmacological and natural therapeutic approaches for comorbidity, by focusing on NLRP3 inflammasome mechanism.
    Hosseini E; Kohan-Ghadr HR; Bazrafkan M; Amorim CA; Askari M; Zakeri A; Mousavi SN; Kafaeinezhad R; Afradiasbagharani P; Esfandyari S; Nazari M
    J Assist Reprod Genet; 2023 May; 40(5):1173-1185. PubMed ID: 36892705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NLRP3 inflammasome in COVID-19 and periodontitis: Possible protective effect of melatonin.
    Şehirli AÖ; Aksoy U; Koca-Ünsal RB; Sayıner S
    Med Hypotheses; 2021 Jun; 151():110588. PubMed ID: 33848919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies.
    He Q; Hu D; Zheng F; Chen W; Hu K; Liu J; Yao C; Li H; Wei Y
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.